Femara (letrozole) is a medication primarily used for the following purposes:
1.Breast Cancer Treatment:
●Hormone Receptor-Positive Breast Cancer: It is prescribed for postmenopausal women with estrogen or progesterone receptor-positive breast cancer. As an aromatase inhibitor, letrozole reduces estrogen production by blocking the aromatase enzyme, which slows or stops cancer growth in hormone-dependent tumors.
●Adjuvant Therapy: Used after surgery (e.g., lumpectomy or mastectomy) to lower the risk of cancer recurrence.
●Metastatic Cancer: Treats advanced or metastatic breast cancer to inhibit tumor spread.
●Sequential Therapy: Sometimes given after tamoxifen to extend protection against recurrence.
2.Fertility Treatment (Off-Label Use):
●Ovulation Induction: Prescribed to women with infertility due to conditions like polycystic ovary syndrome (PCOS). Letrozole stimulates ovulation by increasing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) release, promoting follicle development. Studies suggest it may be more effective and safer than clomiphene (Clomid) for PCOS, with lower risks of multiple pregnancies and thinner endometrial lining.
Additional Notes:
●Side Effects: Common in breast cancer use include hot flashes, joint pain, bone density loss, and fatigue. In fertility treatment, risks include ovarian hyperstimulation or multiple pregnancies.
●Contraindications: Not for premenopausal women (unless combined with ovarian suppression) or those with estrogen-negative tumors.
In summary, Femara (letrozole) is a versatile drug with critical roles in oncology and reproductive medicine, leveraging its estrogen-suppressing effects for cancer treatment and hormonal modulation for fertility. Always consult a healthcare provider for personalized use.
